Edition:
United Kingdom

Cymabay Therapeutics Inc (CBAY.OQ)

CBAY.OQ on NASDAQ Stock Exchange Global Select Market

10.18USD
21 Feb 2019
Change (% chg)

-- (--)
Prev Close
$10.18
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
193,443
52-wk High
$15.59
52-wk Low
$6.33

Chart for

About

CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies to treat metabolic diseases, including serious rare and orphan diseases. The Company's product candidates include Arhalofenate, MBX-8025 and MBX-2982. Arhalofenate is used to treat gout. MBX-8025 is a... (more)

Overall

Beta: 2.08
Market Cap(Mil.): $358.81
Shares Outstanding(Mil.): 43.76
Dividend: --
Yield (%): --

Financials

  CBAY.OQ Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -1.06 -- --
ROI: -182.71 8.92 14.45
ROE: -308.78 10.08 15.96

Earnings vs. Estimates